These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24768782)

  • 21. Influence of ABCB1 genetic variants in breast cancer treatment outcomes.
    Chaturvedi P; Tulsyan S; Agarwal G; Lal P; Agarwal S; Mittal RD; Mittal B
    Cancer Epidemiol; 2013 Oct; 37(5):754-61. PubMed ID: 23707158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
    Helsby N; Yong M; Burns K; Findlay M; Porter D
    Cancer Chemother Pharmacol; 2021 Sep; 88(3):533-542. PubMed ID: 34114066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
    Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
    Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of drug-metabolizing capacity by cytochrome P450 genotyping and expression.
    Temesvári M; Kóbori L; Paulik J; Sárváry E; Belic A; Monostory K
    J Pharmacol Exp Ther; 2012 Apr; 341(1):294-305. PubMed ID: 22262920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer.
    Zhang BL; Sun T; Zhang BN; Zheng S; Lü N; Xu BH; Wang X; Chen GJ; Yu DK; Lin DX
    Chin Med J (Engl); 2011 Jan; 124(2):199-204. PubMed ID: 21362365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy.
    Jounaidi Y; Hecht JE; Waxman DJ
    Cancer Res; 1998 Oct; 58(19):4391-401. PubMed ID: 9766669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma.
    Braybrooke JP; Slade A; Deplanque G; Harrop R; Madhusudan S; Forster MD; Gibson R; Makris A; Talbot DC; Steiner J; White L; Kan O; Naylor S; Carroll MW; Kingsman SM; Harris AL
    Clin Cancer Res; 2005 Feb; 11(4):1512-20. PubMed ID: 15746054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors.
    Su HI; Sammel MD; Velders L; Horn M; Stankiewicz C; Matro J; Gracia CR; Green J; DeMichele A
    Fertil Steril; 2010 Jul; 94(2):645-54. PubMed ID: 19376514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of cytochrome P450 genetic polymorphisms on the toxicity of antitumor agents.
    van Schaik RH
    Ther Drug Monit; 2004 Apr; 26(2):236-40. PubMed ID: 15228172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclophosphamide treatment-induced leukopenia rates in ANCA-associated vasculitis are influenced by variant CYP450 2C9 genotypes.
    Schirmer JH; Bremer JP; Moosig F; Holle JU; Lamprecht P; Wieczorek S; Haenisch S; Cascorbi I
    Pharmacogenomics; 2016 Mar; 17(4):367-74. PubMed ID: 26894931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer.
    Liu L; Wu J; Zhong R; Wu C; Zou L; Yang B; Chen W; Zhu B; Duan S; Yu D; Tan W; Nie S; Lin D; Miao X
    Mol Carcinog; 2013 Dec; 52(12):923-31. PubMed ID: 22821704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.
    Rizzo R; Spaggiari F; Indelli M; Lelli G; Baricordi OR; Rimessi P; Ferlini A
    Breast Cancer Res Treat; 2010 Nov; 124(2):593-8. PubMed ID: 20632082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.
    Chang TK; Yu L; Maurel P; Waxman DJ
    Cancer Res; 1997 May; 57(10):1946-54. PubMed ID: 9157990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
    Zanger UM; Schwab M
    Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450.
    Sonesson A; Rasmussen BB
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):195-202. PubMed ID: 21496210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of second-line treatment with high-dose cyclophosphamide in recurrent metastatic breast cancer.
    Hansen F; Møller P; Skovsgaard T
    Cancer Chemother Pharmacol; 1996; 37(4):377-81. PubMed ID: 8548885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.
    Jabir RS; Naidu R; Annuar MA; Ho GF; Munisamy M; Stanslas J
    Pharmacogenomics; 2012 Dec; 13(16):1979-88. PubMed ID: 23215890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochrome P450 in Cancer Susceptibility and Treatment.
    Mittal B; Tulsyan S; Kumar S; Mittal RD; Agarwal G
    Adv Clin Chem; 2015; 71():77-139. PubMed ID: 26411412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.
    Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Nov; 18(11):1009-15. PubMed ID: 18854779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.